Latest News:
Discovery Acquires Targos Read More
COVID-19 Biospecimens & Biomarker Testing Services
Discovery acquires Targos Molecular Pathology GmbH to power your precision biomarker programs with molecular pathology guided

Tissue Biomarker Services

Make strategic decisions with confidence.

Our experts help you identify and understand biomarkers within your target populations at every stage of research and clinical development – from assay development and validation to clinical trial support and pathologist training for market entry.

Discovery expands global tissue biomarker solutions Learn More

We Are The Biospecimen & Biomarker Specialists

The world’s largest biospecimen inventory and procurement network with preeminent multi-omic service laboratories to accelerate precision medicine programs

Grounded in a Science at your Service attitude:

Biospecimens

Over 10 Million Research-Quality Samples

Discovery has the largest repository of biosamples and the global logistical systems to acquire, biostore, and ship them most efficiently.

Genomic Biomarkers

HudsonAlpha Discovery

Provides comprehensive genomic services to support R&D, translational and pre-clinical drug and diagnostic programs.

Tissue Biomarker Services

Molecular Pathology-Guided Services

High quality IHC services fit for any stage of research and development.

Cell Services

Flow Cytometry + 10x Libraries + Cell Culture + Custom Biospecimen Processing

Advanced flow cytometry services for deep characterization of biospecimens, premium human primary immune cell isolations and custom cell processing services.

Are you interested in

Biospecimens?

Discovery has the largest repository of biosamples and the global logistical systems to acquire, biostore, and ship them most efficiently.

Are you interested in

Biomarker Services?

Discovery has integrated multi-omic biomarker services supporting tissue, genomic and cell based biomarker programs.

Academic Innovation at the

Speed of Industry

HudsonAlpha Discovery, Discovery Life Science’s newest division, provides comprehensive genomic services to support R&D, translational and pre-clinical drug and diagnostic programs.

Propel your projects with the power of discovery Learn More

Researchers value Discovery Life Sciences; they know we will partner with them and provide the resources and expertise necessary to overcome their most complex problems. We will search the globe to obtain the required biospecimens and clinical information, and then apply leading edge technologies to provide the scientific analysis and annotation they need to accelerate their programs.

Glenn BilawskyChief Executive Officer of Discovery Life Sciences
Press
May 18, 2021

Discovery Life Sciences Acquires Targos to Create Market-Leading Global Tissue Biomarker Services

Discovery expands capabilities with addition of leading European service provider to support tissue biomarker programs for research, clinical development and product launch HUNTSVILLE, Ala., May 18, 2021, Discovery Life Sciences™…
Press
November 12, 2020

Discovery Life Sciences Launches TruSight Oncology 500 (TSO500) Solid Tumor FFPE and cfDNA Services to Advance Liquid Biopsy Development and Immunotherapy Clinical Research

Discovery Life Sciences Launches TruSight Oncology 500 (TSO500) Solid Tumor FFPE and cfDNA Services to Advance Liquid Biopsy Development and Immunotherapy Clinical Research HUNTSVILLE, Ala., Nov. 12, 2020, Discovery Life…
View All Press